180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (β180 Life Sciencesβ or the βCompanyβ), today announced that it received notice from the Nasdaq...
PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (β180 Life Sciencesβ or the βCompanyβ), today announced that the Company received a letter on March...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -6.49350649351 | 2.31 | 2.65 | 1.97 | 154889 | 2.24714616 | CS |
4 | 0.47 | 27.8106508876 | 1.69 | 4.8 | 1.46 | 1879914 | 2.85765908 | CS |
12 | 0.35 | 19.3370165746 | 1.81 | 4.8 | 1.31 | 717491 | 2.70762693 | CS |
26 | -1.5279 | -41.4300821606 | 3.6879 | 4.8 | 1.31 | 442109 | 2.91594191 | CS |
52 | -18.17 | -89.3753074274 | 20.33 | 21.28 | 1.31 | 593868 | 5.52402001 | CS |
156 | -164.47 | -98.7037148173 | 166.63 | 172.0089 | 1.31 | 867412 | 51.51138971 | CS |
260 | -197.15 | -98.9162611008 | 199.31 | 247.8607 | 1.31 | 856162 | 75.64403553 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.